PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 33 filers reported holding PDL BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $2,216,000 | +26.9% | 611,850 | +2.0% | 0.12% | -35.1% |
Q2 2020 | $1,746,000 | +3.2% | 600,000 | 0.0% | 0.19% | -14.9% |
Q1 2020 | $1,692,000 | -13.1% | 600,000 | 0.0% | 0.22% | +18.8% |
Q4 2019 | $1,947,000 | +58.3% | 600,000 | +5.4% | 0.19% | +34.8% |
Q3 2019 | $1,230,000 | -31.2% | 569,323 | 0.0% | 0.14% | -23.3% |
Q2 2019 | $1,788,000 | -15.6% | 569,323 | 0.0% | 0.18% | -27.7% |
Q1 2019 | $2,118,000 | +23.3% | 569,323 | -3.9% | 0.25% | +11.2% |
Q4 2018 | $1,718,000 | +277.6% | 592,413 | +242.3% | 0.22% | +357.1% |
Q3 2018 | $455,000 | +11.8% | 173,090 | 0.0% | 0.05% | +2.1% |
Q2 2018 | $407,000 | -19.9% | 173,090 | 0.0% | 0.05% | -21.3% |
Q1 2018 | $508,000 | +7.2% | 173,090 | 0.0% | 0.06% | +17.3% |
Q4 2017 | $474,000 | -21.3% | 173,090 | -2.5% | 0.05% | -31.6% |
Q3 2017 | $602,000 | +37.4% | 177,445 | 0.0% | 0.08% | +33.3% |
Q2 2017 | $438,000 | +8.7% | 177,445 | 0.0% | 0.06% | +3.6% |
Q1 2017 | $403,000 | -25.4% | 177,445 | -29.4% | 0.06% | -28.6% |
Q4 2016 | $540,000 | -41.2% | 251,421 | -8.2% | 0.08% | -51.0% |
Q3 2016 | $918,000 | +6.7% | 273,976 | 0.0% | 0.16% | -8.2% |
Q2 2016 | $860,000 | -5.7% | 273,976 | 0.0% | 0.17% | -2.3% |
Q1 2016 | $912,000 | -6.0% | 273,976 | 0.0% | 0.18% | -3.8% |
Q4 2015 | $970,000 | – | 273,976 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Argent Trust Co | 41,405 | $102,270 | 0.01% |
Diversified Trust Co | 11,029 | $26,469 | 0.00% |
HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
Ancora Advisors LLC | 4,948 | $0 | 0.00% |
Westside Investment Management, Inc. | 500 | $0 | 0.00% |